Olmesartan improves pulse wave velocity and lowers central systolic blood pressure and ambulatory blood pressure in patients with metabolic syndrome.

Ulrike Raff, Stefanie Walker, Christian Ott, Markus Schneider, Roland E Schmieder

Research output: Contribution to journalOriginal Article (Journal)peer-review

5 Citations (Web of Science)
Original languageEnglish
Pages (from-to)98-104
JournalJOURNAL OF CLINICAL HYPERTENSION
Volume17
Issue number2
DOIs
Publication statusPublished - 2015

Keywords

  • PREDICTS CARDIOVASCULAR MORTALITY
  • ARTERIAL STIFFNESS
  • DISEASE
  • AMLODIPINE
  • RISK

Cite this